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HUMAN EMBRYONIC STEM CELLS (hESCs) represent populations of undifferentiated cells with unlimited proliferation properties and with the ability to differentiate into any functional cell type in the human body (1) . Based on these properties hESCs, and derivatives thereof, have provided unique model systems for basic research over the last decade (14) . In addition, industrial applications of hESCs are beginning to find their way into the drug discovery and development processes (27) , and hESC derivatives are also anticipated to be useful for future cell replacement therapies (24) .
One specific application for human pluripotent stem cells is to utilize them to reproducibly generate functional cardiomyocytes, which are normally very hard to come by as primary isolates from cardiac tissue. Substantial evidence has been presented that demonstrates the capacity of hESCs to differentiate into spontaneously contracting cells with a cardiomyocyte-like phenotype (reviewed in Ref. 44 ). However, to fully exploit the potential of these cells for in vitro and in vivo applications, two critical issues need to be more thoroughly addressed. First, improvements of the protocols for cardiomyocyte differentiation are required as a basis for the further development of cost-efficient industrial processes for largescale production of the differentiated cells. Second, the stem cell-derived cardiomyocytes need to be extensively characterized and compared with their in vivo analogs. Although much progress has been made, additional research is required to fully understand the regulatory mechanisms controlling the phenotype of the differentiated cells.
One level of cellular regulation that is important for cellular differentiation involves the family of tiny molecules, known as microRNAs (miRNAs) (16) . These are 19-to 25-nucleotide noncoding RNAs that bind to the 3=-untranslated region of target mRNAs through imperfect matching. Strikingly, in mammalian genomes, miRNAs are predicted to regulate the expression of ϳ30% of the proteincoding genes (4) . Although the biological functions of most miRNAs are still unknown, it has been shown that they play important roles in embryo development, determination of cell fate, cell proliferation, and cell differentiation (28, 44a) . Many miRNAs appear to be expressed in several tissues and the maturation and function of the tissues seems to be influenced by their presence. Interestingly, results from recent studies have indicated important roles for miRNAs in the control of diverse aspects of heart formation and cardiac function (12, 39) .
MicroRNAs bind to mRNAs and negatively regulate their expression, either by repression of translation or by degradation of the mRNA sequence (9) . Increased expression levels of miRNAs can also result in upregulation of previously suppressed target genes either directly, by decreasing the expression of inhibitory proteins and/or transcription factors, or indirectly, by inhibiting the expression levels of inhibitory miRNAs (10) . In a few cases, miRNAs have also been observed to activate the translation of target mRNA by regulation of their stability (10, 43) . In addition, several studies (e.g., Ref. 51 ) have shown that combinatorial regulation by miRNAs is common. Such studies have identified complex regulatory programs that are exceptionally challenging to dissect, and additional research is therefore needed to fully understand these processes.
In the present study we have used microarrays to study, for the first time, the global transcriptional profiles of both miRNA and mRNA from parallel samples of undifferentiated hESCs and cardiomyocyte clusters (CMCs) derived thereof. We have further compared these expression profiles to those of reference samples comprising human fetal and adult heart tissue. Our results show a clear relationship between differentially expressed miRNAs and their predicted target mRNAs, indicating that a high miRNA expression seems to repress the corresponding mRNA levels. However, our results also reveal sets of target genes that display the opposite pattern, which may be explained by indirect regulatory effects. Notably, similar observations have been reported recently by other investigators (10, 43) .
MATERIALS AND METHODS

Generation of CMCs from hESCs
Cardiac differentiation was performed as described previously using hESC line SA002 in passage 26 -67 (Cellartis, http://www. cellartis.com) (32) . Briefly, to initiate differentiation three-dimensional cell aggregates were formed in 96-well plates. After 3-5 days, the aggregates were plated onto gelatin-coated culture dishes for further differentiation and maintenance. Spontaneously contracting clusters were identified by visual inspection and only these were harvested at 3 and 7 wk postplating, by mechanical dissection for subsequent RNA extraction. Specific care was taken only to harvest the beating areas with a minimum of surrounding noncontracting cells.
RNA Extraction and Microarray Experiments
Total RNA was extracted using Ambion miRVana miRNA isolation kit, preserving small molecules, according to the manufacturer's instructions (Ambion, http://www.ambion.com). Quantification of nucleic acids was performed on NanoDrop ND-1000 (NanoDrop, http:// www.nanodrop.com). Microarray experiments were conducted in parallel to measure both miRNA and mRNA expression from paired samples. The material consisted of samples of undifferentiated hESCs and hESC-derived CMCs cultured for 3 wk (CMC3w) and 7 wk (CMC7w) after onset of differentiation. In addition, samples from fetal heart (FH) and adult heart (AH) (Yorkshire Bioscience, http:// www.york-bio.com) were included as reference material (Fig. 1) . The experiments were repeated three times to generate biological replicates, and the human reference RNA material was obtained from three Fig. 1 . A: overview of the experimental design. Dendrograms of the different samples from the microRNA (miRNA) (B) and mRNA (C) experiments, respectively. UD hESC, undifferentiated human embryonic stem cells; CMC, cardiomyocyte cluster; FH, fetal heart; AH, adult heart; CM3w, hESC-derived CMCs cultured for 3 wk; CM7w, hESC-derived CMCs cultured for 7 wk. separate batches. The quality of the RNA and cDNA, labeled by in vitro transcription, was verified using an Agilent Bioanalyzer.
To measure the mRNA expression, fragmented cDNA was hybridized at 45°C for 16 h to whole transcript Gene ST 1.0 arrays (Affymetrix, http://www.affymetrix.com). The microarrays were scanned on a GeneChip Scanner 3000 7G (Affymetrix), and expression signals were extracted and normalized by means of the Expression Console (Affymetrix) applying the Robust Multichip Average (RMA) normalization method.
For the miRNA experiment, samples were labeled using the miRCURY LNA Array power labeling kit (Exiqon, http://www. exiqon.com) and subsequently hybridized at 54°C for 16 h to the miRCURY LNA array version 11.0 (Exiqon) following the manufacturer's instructions. After hybridization, the microarray slides were scanned using the Agilent G2565BA Microarray Scanner System (Agilent Technologies, http://www.agilent.com) and the image analysis was carried out using the ImaGene 8.0 software (BioDiscovery, http://www.biodiscovery.com). The quantified signals were background corrected and normalized using the global Lowess regression algorithm. Hierarchical clustering was performed on the global gene expression data to evaluate the array variability (Fig. 1, B and C) .
Raw expression datasets are available at ArrayExpress (http:// www.ebi.ac.uk/microarray-as/ae/), accession numbers E-MEXP-2654 (mRNA data) and E-MEXP-2655 (miRNA data).
Data Analysis
Identification of differentially expressed miRNAs and mRNAs.
MicroRNAs that were significantly up-or downregulated in CMC3w, CMC7w, FH, and AH compared with undifferentiated hESCs (UD) were identified using the Significant Analysis of Microarray data (SAM) algorithm (37) . SAM controls for false discovery rate (FDR), and miRNAs with an FDR Ͻ 0.05 were here defined as differentially expressed, and thus selected for further analysis. The same procedure was applied for identification of differentially expressed mRNA sequences. The gene lists were filtered to only include genes with known official gene symbols.
Clustering of differentially expressed miRNAs. To group miRNAs that show similar expression profiles across the different samples, a two-way hierarchical clustering was performed with clustering software available at the GEPAS web-site (http://gepas.org/). Pearson correlation was used as the distance measure and UPGMA clustering was applied to generate the dendrogram.
Investigation of the transcriptional effects at mRNA level of up-and downregulated miRNAs. The correlation between miRNA expression and mRNA expression in the CMCs and tissue samples was investigated applying the following approach (Fig. 2) . 1) Only the miRNAs that were significantly up-or downregulated in all four samples (CMC3w, CMC7w, FH, and AH) were selected for further investigation. 2) For each of these miRNAs, putative target genes were identified using the software tool microT v3.0 (http://diana.cslab. ece.ntua.gr/microT/). The parameter target score threshold was set to 12, which is considered as a moderate threshold for identification of target genes for miRNAs. 3) To explore if the mRNA expression levels of predicted target genes were affected by significant changes in miRNA expression, the number of target genes that were identified as significantly up-or downregulated in the mRNA data was calculated as follows. For each miRNA the number of target genes that were identified as upregulated in the mRNA data was divided with the total number of identified target genes for that particular miRNA. A similar calculation was done for the downregulated miRNAs. For an mRNA sequence to qualify as differentially expressed it had to be differentially expressed in all four cell and tissue samples. Using these restrictions, we calculated the percentages of up-and downregulated target genes of each miRNA.
Functional annotation of the differentially expressed target genes. Using the DAVID bioinformatic resource (http://david.abcc.ncifcrf. gov/), a functional annotation analysis of the differentially expressed genes was conducted. Gene Ontology (GO) annotations including biological process (BP), molecular function (MF), and cellular component (CC) (3) were investigated, and significantly overrepresented (P Ͻ 0.05) GO annotations were identified. The set of regulated genes was also investigated for significantly overrepresented (P Ͻ 0.05) pathways among the genes using the KEGG (http://www.genome.jp/ kegg) and BioCarta pathway (http://www.biocarta.com) databases.
Real-time qPCR
To verify the results from the microarray experiments, the expression of five miRNAs and five corresponding target mRNAs was monitored in UD, CMC7w, FH, and AH using real-time qPCR as described previously (31) . The expression levels of the following pairs of miRNAs-mRNAs were determined: miR-100 -FZD5, miR-499-5p -LIN28B, miR-302e -RYR2, miR-302c* -LIFR, and miR-18a -CCND2, which represent both upregulated and downregulated transcripts. The primers and probes for the miRNA and mRNA analysis were purchased from Exiqon (http:// www.exiqon.com) and Applied Biosystems (http://www.appliedbiosystems. com), respectively.
RESULTS
The successful differentiation of hESCs to CMC was confirmed by the microarray analysis and, as shown in Fig. 3 , markers of pluripotency (POU5F1, NANOG, DNMT3B, and LIN28) were downregulated in the CMC samples to background levels similar to those observed in FH and AH. On the other hand, cardiomyocyte markers (MYH7, MYH6, TNNT2, and PLN) were substantially upregulated in the CMC-samples. As expected, the expression of MHY6 is higher in CMCs compared with FH and AH, while the opposite pattern is observed for MYH7. TNNT2 and PLN are expressed at com- parable levels among the differentiated samples and heart tissues.
Using the SAM statistical algorithm, we identified differentially expressed miRNAs in the four samples (CMC3w, CMC7w, FH, and AH) compared with UD. Table 1 shows the number of up-and downregulated miRNAs, and notably there are more than twice as many upregulated than downregulated miRNAs in the CMC samples, indicating the importance of increased expression of selected miRNAs during cardiac development. The arrays used in this study contain also a set of yet unpublished miRNAs, denoted with PLUS, which have been identified by Exiqon using cloning and sequencing of human normal and diseased tissue. Interestingly, some of these miRNAs demonstrate differential expression in our experimental setup (third column in Table 1 ). In total, there were ϳ500 (range 472-536) miRNAs expressed in each of the sample groups. When the expression range was divided into four quartiles, the vast majority of the differentially expressed miRNAs (75%) were in the second quartile, but the whole expression range was represented with 10% in the first, 7% in the third, and 2% in the fourth quartile respectively. A list with fold change of all differentially expressed miRNAs is available as additional material (online Supplemental Table S1 ). 1 
Differentially Expressed miRNAs
As shown in Fig. 4A , there is a highly concordant miRNA expression pattern in the different samples. The significance threshold applied in all analyses was FDR Ͻ 0.05. In total, 147 miRNAs were upregulated in CMC3w, and 130 of these (88%) were also upregulated in CMC7w (Fig. 4A) . In total, 70 miRNAs were downregulated in both the CMC3w and the CMC7w, respectively, and 48 of these (69%) are overlapping between these two samples. In the human heart tissue samples, more miRNAs were detected as differentially expressed in FH compared with the situation in the AH. In total 79 out of 84 upregulated miRNAs in AH are also upregulated in FH, and 37 out of 38 downregulated miRNAs in AH are also downregulated in FH (Fig. 4A) . Interestingly, the overlap between the CMCs and the heart tissue samples was large, and 61 of the 79 miRNAs (77%) that were upregulated in the heart tissues were hESC, human embryonic stem cell; UD, undifferentiated hESC; CMC3w, hESC-derived cardiomyocyte clusters cultured for 3 wk; CMC7w, hESCderived CMCs cultured for 7 wk; FH, fetal heart; AH, adult heart. also upregulated in both CMC groups. Regarding downregulated miRNAs, 24 of the 37 miRNAs (65%) that were downregulated in both FH and AH were also downregulated in the CMC groups (Fig. 4A) . Only the intersection of miRNAs that were significantly up-or downregulated in all four cell and tissue samples (CMC3w, CMC7w, FH, and AH) were finally selected for further studies regarding their potential effect on target mRNA expression.
Differentially Expressed mRNAs
In a similar way as for the miRNAs, the intersections of significantly up-or downregulated mRNAs (FDR Ͻ 0.05) in the four cell and tissue samples were determined, and the results are shown in Fig. 4B . In total, 3,138 mRNAs were upregulated in CMC3w, and 1,871 (60%) of these were also upregulated in CMC7w. Notably, there was a pronounced increase (54%) in the number of upregulated mRNAs in CMC7w compared with CMC3w. In contrast to what was observed in the miRNA data, there were more upregulated mRNAs in the heart tissue samples than in the hESC-derived CMC samples. All together, 4,194 mRNAs were upregulated in the FH, and 2,165 (52%) of these were also upregulated in AH. A comparison of mRNA expression between heart tissue and CMCs demonstrates an overlap of 63% between these two groups, meaning that 1,177 of the 1,871 mRNAs that were upregulated in the CMCs were also upregulated in both FH and AH. In contrast to what was observed in the miRNA data, there were more downregulated than upregulated mRNAs in the cell and tissue samples. Generally, higher overlaps between pairs of samples (CMC3w-CMC7w and FH-AH) were observed for the http://physiolgenomics.physiology.org/ downregulated mRNAs (ϳ84%) than for the upregulated mRNAs (ϳ63%). Interestingly, there were more than twice as many downregulated (2,613) than upregulated (1, 177) mRNAs that overlapped between all four samples, which is an opposite pattern of what is observed in the miRNA data.
Real-time qPCR Analysis of miRNA and mRNA Expression
The results from real-time qPCR analysis showed high concordance with our microarray results for all 10 investigated transcripts (Fig. 5) . For those miRNAs that showed significantly induced expression, a clear downregulation of corresponding target mRNA was observed and vice versa.
Clustering of Differentially Expressed miRNAs
To group differentially expressed miRNAs according to their expression profiles a hierarchal clustering was conducted, and the results are shown as a combined dendrogram/heat map where low expression levels are represented with blue color and high levels are shown in red (Fig. 6 ). As expected, the samples cluster in three main groups, UD hESCs, hESCderived CMCs, and cardiac tissue samples.Four distinct clusters (and one singleton) among the upregulated and three among the downregulated miRNAs were identified (see letters A-G, Fig. 6 ).
Posttranscriptional Regulation of mRNA Expression
The transcriptional patterns of differentially expressed miRNA target genes were determined. Interestingly, the results demonstrate that on average ϳ26% of the upregulated miRNA target genes ( Table 2 ) and ϳ29% of the downregulated miRNA target genes (Table 3) were differentially expressed in all four cell and tissue samples. Of particular note is that among the target genes displaying differential expression, both up-and downregulated genes were observed. As shown in Tables 2 and 3 , there were large variations both in the number of putative target genes identified and in the target gene expression patterns across different miRNAs. No target genes were identified for 11 of the upregulated miRNAs (miR-138-1*, miR-151-5p, miR-208a, miR-208b, miR-451, miRPlus-E1047, miRPlus-E1065, miRPlus-E1117, miRPlus-E1141, miRPlus-E1202, miRPlus-E1219) and two of the downregulated miRNAs (miR-25*, miRPlus-E1038) using 12 as the score threshold (see MATERIALS AND METHODS). Notably, to increase the validity of the results, this analysis was restricted to only include target genes of miRNAs that were significantly up-or downregulated in all four samples and only mRNAs that were significantly up-or downregulated in all four cell and tissue samples qualified as differentially expressed. 
Overrepresented Pathways Among the Differentially Expressed Target Genes
KEGG and BioCarta pathways containing significantly (P Ͻ 0.05) many of the differentially expressed target genes were identified and listed in Tables 4 and 5 . In total, 19 KEGG pathways were overrepresented, and these are shown in Table 4 . Among these are "Wnt signaling pathway," "Focal adhesion," and "Calcium signaling pathway."
Moreover, three BioCarta pathways were identified as overrepresented among the differentially expressed target genes (Table 5) , and these are "BTG family proteins and cell cycle regulation," "regulation of PGC-1a," and "NFAT and hypertrophy of the heart."
Functional Annotation of the Differentially Expressed Target Genes
Using DAVID and in total 813 target genes, which were defined as differentially expressed in previous steps as input, we determined significantly overrepresented annotations. Interestingly, several of these relate to cardiac function and cardiac development. Fig. 7 shows pie charts of the overrepresented annotations in the three categories BP, MF, and CC. Among the enriched annotation terms for the BP category were "heart development," "heart contraction," "organ morphogenesis," and "regulation of transcription" (Fig. 7A) . For the MF category, "ion binding activities" and "protein kinas activity" were the two major groups of enriched annotations (Fig. 7B ) and for the category CC "various parts of the nucleus" and "intracellular organelles" were identified as significantly enriched (Fig. 7C) .
DISCUSSION
Microarrays have proven to be powerful tools in large-scale analysis of mRNA expression. More recently, microarrays have also been applied for global analysis of miRNA expression in various tissue types. In this study, we present a comprehensive analysis of parallel miRNA and mRNA expression in hESC-derived CMCs and in heart tissue samples. Our results show that miRNAs are abundantly expressed in cardiac tissue, and, notably, more than twice as many upregulated than downregulated miRNAs were detected in the hESC-derived CMCs and in the heart tissue samples compared with undifferentiated hESCs. Furthermore, the CMCs and FH showed approximately twice as many upregulated miRNAs than the AH tissue, indicating that CMCs and FH constitute more immature cell populations that undergo developmental changes known to be tightly regulated by miRNAs. In consensus with the proposed function that miRNAs induce degradation of mRNAs (4), the quantitative difference in the number of differentially expressed miRNAs is also reflected in the mRNA expression patterns. The number of downregulated mRNAs is substantially higher than the number of upregulated mRNAs, which is in line with the reverse pattern observed for miRNA expression. We also corroborated some of the results obtained using microarrays with real-time qPCR analysis of a selection of miRNAs and mRNAs.
Many of the upregulated miRNAs in our study have previously been reported by other investigators to be expressed in cardiac tissue in human or in other species. These miRNAs include let-7 (33, 49), miR-1 (33, 49, 50) (48), and miR-451 (33), lending support to our experimental set-up and analysis. Importantly, we observed increased expression of miR-1 and miR-499, which have been functionally associated with differentiation of cardiac progenitor cells (30) . In addition, miR-199 was recently reported to regulate the expression of endothelin 1 (47), which is a potent vasoconstrictor peptide normally expressed by the endothelium, but also expressed in cardiac myocytes (20) . Moreover, our data show increased expression of miRNAs (e.g., miR-486 and miR-99) that have not previously been reported to be induced in cardiac tissues. In future studies, it will be interesting to determine the possible roles of these miRNAs in cardiac development and functionality. In addition, 14 of the newly detected PLUS miRNAs (see Table   2 ) also showed significant upregulation in our cell and tissue samples.
Equally important, but less reported on, is the downregulation of miRNAs. Table 3 shows 24 miRNAs that were identified as significantly downregulated in the CMCs and heart tissue samples. To the best of our knowledge, none of these miRNAs are previously reported as differentially expressed in cardiomyocytes or heart tissue. However, miR-302b/c/d and miR-367 are associated with pluripotency and were demonstrated to be highly expressed in undifferentiated hESC (11, 18, 36) . MiR-18a/b and miR-302 have been proposed to be regulators of the estrogen receptor-␣ and suggested to participate in estrogen receptor signaling in breast cancer cell lines (5, 17) . MiR-124a is a brain-specific miRNA and suggested to have a role in neuronal differentiation (29) , which may explain why it is downregulated in our data. Both miR-18, miR-20, and miR-363 have been reported as not expressed in the heart in organ expression studies (2) . Functional annotations for miR-1308, miR-302e/f, and miR-492 are still lacking and further research regarding their tissue expression and functionality is needed.
We hypothesized that some of the genes that were upregulated in cardiomyocytes and heart tissue could be posttranscriptionally regulated by miRNAs. Thus, we explored the list of predicted target genes of the downregulated miRNAs. In line with our hypothesis, the upregulated target genes (online Supplemental Table S2 ) included several well-known marker genes for mesoderm and heart development (e.g., HAND1, HAND2, PROX1, MEF2A, MEF2D, GATA6, VEGFC). In addition, ion channels (e.g., CACNA1C, CACNB2, RYR2) and calcium ion binding genes (e.g., DST), known to be important for heart contraction, were also found among the target genes for downregulated miRNAs. To further evaluate our target gene predictions we also compared our results to published data from experimental studies. Similar to our results, SMC1A2 was reported to be a target gene of let-7e (15) , and miR-1 is modulating the expression of UST, TRIM2, TIMP3, and TMSL1 (19) (50). In addition, LIN28 has been shown to be a target gene of both miR-125a and miR-125b (46) , and EZH2 was reported to be a target gene of miR-26a (45) . These data are in line with our results and support the reliability of our target gene predictions. The clustering analysis (Fig. 6 ) revealed novel groups of coexpressed miRNAs, potentially participating in similar functions or biological processes. Cluster A contained miR-499-5p previously reported to be expressed in cardiac progenitor cells (30) and the expression pattern of e.g., miR-365 highly resembles that of miR-499-5p. Moreover, miR-22, reported to be particularly enriched in fetal heart (33) , is also present in this cluster. Cluster B contained miR-208b and this miRNA plays a key role in the expression of ␤MHC in the response to cardiac stress, and it has been suggested to be a regulator of contractility (38, 41) . Notably, nine of the novel PLUS miRNAs were also located within this cluster, and their expression pattern closely resembles that of miR-208b, making these miRNAs particularly interesting for further studies in the context of cardiac stress and contractility. Remarkably, miR-208a is clustered as a singleton and showed extremely high expression in all CMC samples, compared with the corresponding heart tissue samples. Cluster C is the largest cluster and contained many miRNAs (e.g., miR-1, miR-23, miR-30, miR-125, miR-133) that have been coupled to various cardiac diseases (38) . These miRNAs have expression profiles similar to those of miR-100, miR-143, and miR-145, which were grouped into the same cluster. MiR-143 and miR-145 are reported to be cotranscribed in multipotent murine cardiac progenitors and direct transcriptional targets of serum response factor, myocardin, and Nkx2.5 (6) . Moreover, cluster C also contained miR-24, previously reported to be induced in fibroblasts compared with heart tissue (33) . As previously demonstrated miR-24 is regulated by TGF-␤ and expressed in multiple murine tissues, including the heart (31). It has been speculated that miR-24 plays different roles in the homeostasis of various tissues, and that it might function during both differentiation and homeostatic maintenance of cardiac and skeletal muscle tissues. This is supported by our data, where miR-24 showed high levels in all cell and tissue samples.
Cluster C also contained several miRNAs that have previously been reported to be expressed in heart tissue, including miR26a/b (33, 49) , miR-27a/b (33, 40) , and miR-422a (48) . These miRNAs were in our analysis grouped together with miRNAs not yet associated with cardiogenesis or heart cells (e.g., miR-152, miR-378, miR1297, miRPLUS-F1037 miRPLUS-E1219, miRPLUS-C1049). Cluster D contained let-7e, miR99a, miR-140, miR-126, miR-126*, miR-144, miR-199b, and miR-486. Notably, the expression of several of these miRNAs (miR-144, miR-126, miR-126*, miR-99, miR-98), which are highly expressed in the heart tissue samples, deviates largely in the samples of CMCs. Further investigations of putative implications of low expression of these miRNAs in cultured CMCs are needed.
The pathway analysis identified significant effects on several cellular pathways which have previously been reported to be involved in cardiac development. For example, "Wnt signaling" has been documented as a critical pathway for multiple aspects of heart development (35) . Also the "focal adhesion" pathway is reported to have implications for cardiac performance, in particular for the beat-to-beat regulation (26) . It also influences the proliferation, differentiation, growth, and survival of the cellular components that comprise the human myocardium (21, 22) . Moreover, the "calcium signaling" pathway is crucial for excitation-contraction coupling in both cardiac and smooth muscles and affects the level of contractile force in the tissue (13, 23) . The "regulation of PGC-1a" pathway, regulated by MEF2/HDAC, is significantly modulated in our data, and interestingly, it has been shown to be important for cardiac mitochondrial function in mice (7) . In addition, the "NFAT and hypertrophy of the heart" pathway has previously been reported to be essential for cardiac development in rodents (8, 20) .
In conclusion, we have for the first time performed a global comparative study of miRNA and mRNA expression in hESCderived CMCs and in human fetal and adult heart tissues. Our results demonstrate interesting correlations between differentially expressed miRNAs and their corresponding target genes. We identified sets of miRNAs that were significantly up-vs. downregulated in both the cell and heart tissue samples and explored the functions of their putative target genes. These results provide an excellent starting point for further studies regarding the functional properties of the differentially expressed miRNAs in the context of cardiogenesis and regeneration of cardiac tissue.
